ClinicalTrials.Veeva

Menu

Validating a Modified COMPASS 31questionnaire for Treatment Outcomes

Brooke Army Medical Center logo

Brooke Army Medical Center

Status

Enrolling

Conditions

Cervicogenic Headache
Headache, Migraine
Persistent Post Traumatic Headache

Treatments

Other: COMPASS 31 questionnaire

Study type

Observational

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT05302479
C.2021.128e

Details and patient eligibility

About

Eligible participants will complete the COMPASS 31 (year), modified COMPASS 31(one month) and the NSI (one month) questionnaires at baseline and complete the modified COMPASS 31 and the NSI after usual care of treatment.

The investigators will

  1. Compare results for the COMPASS 31(year) to the modified COMPASS 31(month) at baseline.
  2. Compare modified COMPASS 31(month) to the NSI at baseline and post intervention.

Full description

The Composite Autonomic Symptom Score (COMPASS 31) is a validated questionnaire designed to measure self reported autonomic symptoms in the last year in individuals with migraine and post-concussive symptoms. In order to use this questionnaire to measure response to treatment it would be preferable to determine if the results of the COMPASS 31 are similar if the patient is asked to complete this thinking about symptoms in the last year as per the usual questionnaire, compared to a modified COMPASS 31 where symptoms in the past month will be assessed.

This prospective trial will compare results of the COMPASS 31 (year) to the modified COMPASS 31 (month). Since the present gold standard for outcome measures in post-concussive treatment is the neurobehavioral symptom inventory (NSI), this study will also compare results of the modified COMPASS 31(month) to the NSI outcome measure at baseline and post treatment to validate the utilization of the modified version of the COMPASS 31(month) for use in the post-concussive population as an outcome measure for self-reported autonomic nervous system symptoms.

Enrollment

35 estimated patients

Sex

All

Ages

18 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who present to the BAMC_BIRS clinic for treatment of headache between the ages of 18-64.

Exclusion criteria

  • Normal composite autonomic symptom score.

Trial contacts and locations

1

Loading...

Central trial contact

Matt H Hammerle, DPT; Lisa H Lu, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems